Related Experiment Video
Updated: Dec 21, 2025

Non-Invasive Electrical Brain Stimulation Montages for Modulation of Human Motor Function
Published on: February 4, 2016
Endovascular Neuromodulation: Safety Profile and Future Directions
Samad A Raza1, Nicholas L Opie2, Andrew Morokoff1
1Department of Neurosurgery, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Endovascular neuromodulation uses the Stentrode device for brain-computer interfaces. This review examines long-term safety and viability, drawing lessons from cardiac devices for human application.
Area of Science:
- Neurology
- Neural Engineering
- Biomedical Devices
Background:
- Endovascular neuromodulation merges interventional neurology and neural engineering.
- The Stentrode is a stent-electrode array for endovascular neural interfaces.
- Conceptual validation exists in ovine models, but human data is lacking.
Purpose of the Study:
- To review existing literature on transvenous leads.
- To identify potential risks and research needs for the Stentrode.
- To optimize the Stentrode for human application.
Main Methods:
- Literature review of transvenous lead devices.
- Analysis of safety and long-term viability data.
- Comparison with cardiac pacemaker/defibrillator lead literature.
Main Results:
- Technical precedence for venous sinus stenting exists for other conditions.
- Long-term intracranial venous lead implantation is novel.
- Cardiac device literature offers insights into potential risks and management.
Conclusions:
- Further research is needed to ensure the Stentrode's long-term safety and viability in humans.
- Lessons from cardiac device implantation are crucial for optimizing endovascular neuromodulation.
- Addressing potential risks is key for successful human application.
More Related Videos
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
08:37Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
Published on: December 22, 2020